Peregrine Pharma Initiates Bavituximab Study

31-12-2013 Zacks.comComments (0)

Jazz PharmaceuticalsPeregrine PharmaceuticalsPharmaceuticalVanda Pharmaceuticals

Peregrine Pharma, a biopharmaceutical company, carries a Zacks Rank #3 (Hold). Some better-ranked stocks include Vanda Pharmaceuticals, Inc. (VNDA - Snapshot Report) and Jazz Pharmaceuticals (JAZZ - Snapshot Report). Both carry a Zacks Rank #1 ...

Read more on Zacks.com

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top